Concepedia

Alexander Wilder

AW

Statistics

Publications

4

Citations

173

H-Index

4

Active since

1936

Affiliations

Pfizer (United Kingdom)(Current)

Alexander Wilder is an author at Pfizer (United Kingdom) specializing in antiviral therapy, pharmacology, and antiviral drug design.

Publications per year

1936–2011

4

Publications

4

Development of a Bulk Enabling Route to Maraviroc (UK-427,857), a CCR-5 Receptor Antagonist

Sarah J. Haycock-Lewandowski, Alexander Wilder, Jens Åhman · Organic Process Research & Development · 2008 · 93 citations

, , +16

Process Research and Scale-up of a Commercialisable Route to Maraviroc (UK-427,857), a CCR-5 Receptor Antagonist

Jens Åhman, Melissa Birch, Sarah J. Haycock-Lewandowski et al. · Organic Process Research & Development · 2008 · 42 citations

, , +14

The use of environmental metrics to evaluate green chemistry improvements to the synthesis of (S,S)-reboxetine succinate

Georges Assaf, Graham Checksfield, Doug Critcher et al. · Green Chemistry · 2011 · 21 citations

, , +11

METAL CATALYSTS IN BIOLOGIC OXIDATIONS

M. S. Kharasch, R. R. Legault, Alexander Wilder et al. · Journal of Biological Chemistry · 1936 · 17 citations · Full text

, , +12

1–4 of 4